CHD Chemicals Limited has successfully concluded its board meeting held on April 9, 2026, addressing key matters related to an upcoming Extraordinary General Meeting (EGM). The company formally notified the Bombay Stock Exchange regarding the meeting outcome, demonstrating adherence to regulatory compliance under Regulation 30.

Meeting Execution and Timeline

The board meeting took place as scheduled on Thursday, April 9, 2026, at 1:00 PM at the company's corporate office located at Plot No 331, Industrial Area, Phase II, Panchkula-134113. The meeting was successfully concluded at 2:00 PM, completing all agenda items within the allocated timeframe.

Key Decisions and Approvals

The board successfully addressed two critical agenda items during the meeting. The primary decision involved the appointment of M/s Neeraj Jindal & Associates as the scrutinizer for the upcoming Extraordinary General Meeting. Additionally, the board approved the draft notice for convening the EGM, ensuring all regulatory requirements are met.

Regulatory Compliance and Documentation

The outcome notification was digitally signed by Mahtab Singh, Director of CHD Chemicals Limited, on April 9, 2026, at 14:18:24 +05'30'. The formal communication was submitted to the Manager (CRD) at Bombay Stock Exchange Ltd., referencing Script Code 539800, ensuring complete transparency and regulatory adherence.

The company operates under Corporate Identification Number L24232CH2012PLC034188, with its registered office at SCF 214, Motor Market, Manimajra, Chandigarh-160101. This timely notification reflects the company's commitment to maintaining corporate governance standards and meeting stock exchange compliance obligations under applicable regulations.

CHD Chemicals Limited conducted a separate meeting of independent directors on March 31, 2026, as part of its corporate governance practices. The meeting was held at the company's corporate office located at Plot No. 331, Industrial Area, Phase II, Panchkula, and was convened to address several key governance matters.

Meeting Details and Agenda

The independent directors' meeting commenced at 3:00 PM and concluded at 4:55 PM on March 31, 2026. The session was specifically organized to fulfill regulatory requirements and enhance the company's governance framework through comprehensive board evaluation processes.

Key Areas of Review

The independent directors focused on three primary areas during their deliberations:

• Board Performance Evaluation: Review of the performance of non-independent directors and assessment of the board of directors as a whole
• Information Flow Assessment: Evaluation of the quality, quantity, and timeliness of information flow between company management and the board of directors
• Chairperson Performance Review: Assessment of the company's chairperson performance, incorporating feedback from both executive and non-executive directors

Regulatory Compliance

The company has informed the Bombay Stock Exchange about the meeting outcomes under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. CHD Chemicals Limited, with script code 539800 on BSE, maintains its registered office at Plot No. 45, Industrial Area, Phase I, Chandigarh, while operating from its corporate office in Panchkula.

The meeting represents the company's commitment to maintaining robust corporate governance standards and ensuring effective board oversight of management activities.